ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,983.25
-0.50%
US Tech 100
20,786.00
-1.22%
다우존스 지수
43,461.21
0.08%
Bitcoin
91,845.80
0.44%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Sonnet BioTherapeutics Holdings Inc (SONN) 시세

Sonnet BioTherapeutics Holdings Inc

Sonnet BioTherapeutics Holdings Inc (SONN)

NASDAQ
1.51
0.07
(4.86%)
종가: 25 2월 6:00AM
15분 지연
1.51
0.00
( 0.00% )
시간외 거래: 8:55AM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

주요 통계 및 세부정보

가격
1.51
매수가
1.48
매도가
1.61
거래량
114,523
1.39 일간 변동폭 1.55
1.38 52주 범위 18.7192
market_cap
4.629M
전일 종가
1.44
개장가
1.40
최근 거래 시간
91
@
1.5
마지막 거래 시간
07:53:22
재정 규모
US$ 169,034
VWAP
1.476
평균 볼륨(3m)
1,161,018
발행 주식
3,065,701
배당수익률
-
주가수익률
-0.63
주당순이익(EPS)
-2.43
매출
19k
순이익
-7.44M

Sonnet BioTherapeutics Holdings Inc 정보

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and... Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others. 더 보기

섹터
Pharmaceutical Preparations
산업
Management Consulting Svcs
웹사이트
www.sonnetbio.com
본부
Wilmington, Delaware, USA
설립됨
2020
Sonnet BioTherapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SONN. The last closing price for Sonnet BioTherapeutics was US$1.44. Over the last year, Sonnet BioTherapeutics shares have traded in a share price range of US$ 1.38 to US$ 18.7192.

Sonnet BioTherapeutics currently has 3,065,701 shares in issue. The market capitalisation of Sonnet BioTherapeutics is US$4.41 million. Sonnet BioTherapeutics has a price to earnings ratio (PE ratio) of -0.63.

SONN 최신 뉴스

추가 뉴스

Form 3 - Initial statement of beneficial ownership of securities
Edgar (US Regulatory)
22 2월 2025
SONN (4.86%)

Form 8-K - Current report
Edgar (US Regulatory)
19 2월 2025
SONN (4.86%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
14 2월 2025
SONN (4.86%)

Form 8-K - Current report
Edgar (US Regulatory)
13 2월 2025
SONN (4.86%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
03 2월 2025
SONN (4.86%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
03 2월 2025
SONN (4.86%)
기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.08-5.031446540881.591.691.381466451.48856773CS
4-0.3-16.57458563541.811.931.38868261.60213573CS
12-1.16-43.44569288392.674.851.3811610181.93882755CS
26-4.57-75.16447368426.0810.021.387539482.58679672CS
52-12.73-89.396067415714.2418.71921.384308423.67584101CS
156-639.13-99.7642982018640.641649.40161.381899173549.42554716CS
260-15324.57-99.990147513315326.0839916.81.3822592142543.06855459CS

SONN - Frequently Asked Questions (FAQ)

What is the current Sonnet BioTherapeutics share price?
The current share price of Sonnet BioTherapeutics is US$ 1.51
How many Sonnet BioTherapeutics shares are in issue?
Sonnet BioTherapeutics has 3,065,701 shares in issue
What is the market cap of Sonnet BioTherapeutics?
The market capitalisation of Sonnet BioTherapeutics is USD 4.41M
What is the 1 year trading range for Sonnet BioTherapeutics share price?
Sonnet BioTherapeutics has traded in the range of US$ 1.38 to US$ 18.7192 during the past year
What is the PE ratio of Sonnet BioTherapeutics?
The price to earnings ratio of Sonnet BioTherapeutics is -0.63
What is the cash to sales ratio of Sonnet BioTherapeutics?
The cash to sales ratio of Sonnet BioTherapeutics is 246.77
What is the reporting currency for Sonnet BioTherapeutics?
Sonnet BioTherapeutics reports financial results in USD
What is the latest annual turnover for Sonnet BioTherapeutics?
The latest annual turnover of Sonnet BioTherapeutics is USD 19k
What is the latest annual profit for Sonnet BioTherapeutics?
The latest annual profit of Sonnet BioTherapeutics is USD -7.44M
What is the registered address of Sonnet BioTherapeutics?
The registered address for Sonnet BioTherapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Sonnet BioTherapeutics website address?
The website address for Sonnet BioTherapeutics is www.sonnetbio.com
Which industry sector does Sonnet BioTherapeutics operate in?
Sonnet BioTherapeutics operates in the MANAGEMENT CONSULTING SVCS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MFImF International Ltd
US$ 1.25
(108.44%)
2.48M
BREABrera Holdings PLC
US$ 1.03
(63.16%)
4.46M
WAFUWah Fu Education Group Ltd
US$ 2.92
(63.13%)
9.7M
MBRXMoleculin Biotech Inc
US$ 1.63
(52.34%)
4.87M
DOMHDominari Holdings Inc
US$ 9.9989
(31.91%)
1.2M
SXTCChina SXT Pharmaceuticals Inc
US$ 0.4863
(-42.11%)
14.61M
FGENFibroGen Inc
US$ 0.428
(-26.23%)
594.68k
YYAIConnexa Sports Technologies Inc
US$ 0.985
(-22.44%)
2.4M
ELABPMGC Holdings Inc
US$ 1.228
(-21.78%)
86.42k
RETOReTo Eco Solutions Inc
US$ 0.4699
(-20.36%)
1.32M
SXTCChina SXT Pharmaceuticals Inc
US$ 0.4863
(-42.11%)
14.61M
WAFUWah Fu Education Group Ltd
US$ 2.92
(63.13%)
9.7M
DGLYDigital Ally Inc
US$ 0.0929
(-0.75%)
5.79M
MBRXMoleculin Biotech Inc
US$ 1.63
(52.34%)
4.87M
SMCISuper Micro Computer Inc
US$ 50.81
(-1.55%)
4.65M

SONN Discussion

게시물 보기
tw0122 tw0122 3 월 전
Cash out time 5.45 + 150%
👍 1
LowFloatLopes LowFloatLopes 3 월 전
I'm at $2.50 out at $4.50 in less than 8 mins lol 
👍️0
tw0122 tw0122 3 월 전
Don't stay in long this one hardly ever stays up high long 3.49 +'80%
👍️0
Monksdream Monksdream 3 월 전
SONN, 10Q due DEC 13
👍️0
tw0122 tw0122 4 월 전
Reverse split was September 
👍️0
Invest-in-America Invest-in-America 4 월 전
SONN: They announced a DUMP-to-Market routine!!! (The WORST thing any firm could do when their stock is SOARING!!!! WOW!!!!)
👍️0
Tiger Money Tiger Money 4 월 전
What is going on here?  Reverse?  Where is the float on this train wreck now?
👍️0
bigfart bigfart 4 월 전
So insiders can dump before the RS
👍️0
tw0122 tw0122 4 월 전
Reverse split offering and now some news $8s
👍️0
tw0122 tw0122 5 월 전
May the reverse split gods come soon. Keep an eye!
👍️0
BooDog BooDog 5 월 전
Another split here too.

https://www.globenewswire.com/news-release/2024/09/25/2952951/0/en/Sonnet-BioTherapeutics-Announces-1-for-8-Reverse-Stock-Split.html
👍️0
Clemdane Clemdane 6 월 전
Big jump today!
👍️0
Awl416 Awl416 6 월 전
Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
👍️ 1
Monksdream Monksdream 6 월 전
SONN new 52=low
👍️0
Clemdane Clemdane 6 월 전
Big jump back up today. It's a very "risk on" stock so when the market is scared, everyone dumps it.
👍️0
Monksdream Monksdream 6 월 전
SONN new 52 week low
👍️0
Monksdream Monksdream 6 월 전
SONN new 52 week low
👍️0
Monksdream Monksdream 8 월 전
SONN new 52 week low
👍️0
Monksdream Monksdream 8 월 전
SONN new 52 week low
👍️0
BooDog BooDog 10 월 전
I see 76 followers here. And I have a target price of around 1.50 for support.

GL.

I do own shares and am looking for this to have a good future.
👍️0
maq1214 maq1214 11 월 전
Something must be happening behind closed doors. This stock has been ridiculously quite since the RS. Glad it’s greening again !
👍️0
81vette 81vette 11 월 전
23,198 watchers now,word is spreading like wildfire,somebody with lots of followers must be promoting this
👍️0
81vette 81vette 11 월 전
They are rare,not 1 in a million lotto rare but only a few per year maybe happen,the chart is great,how many bio pharma are bullish for 5 months straight (1 in a million lol) has accumulated also and that is very promising
👍️0
maq1214 maq1214 11 월 전
Do you think we are likely to see a merger/ partnership? I;m really hoping the reverse split last year cost me a lot
👍️0
81vette 81vette 11 월 전
$2.23 is 5 month high,next res. $5 mental,$7.57(sma200),big gaps to fill,mental 10/15/20/25 ect. lots of blue sky past 7.57,any kind of merger/buyout news could send it,thats the hype/hope/pump talk right now
👍️0
81vette 81vette 11 월 전
254k short,could squeeze with ZERO BORROW,73% fee(no rebate),5 months of accumulation= in the know are loading
👍️0
81vette 81vette 11 월 전
5 month uptrend(since r/s)accumulation,zero borrow,moving today on low vol(up13%),clinical trials different stages,float 2.78m,o/s 3m
👍️0
BooDog BooDog 12 월 전
Riding free again.
👍️0
Monksdream Monksdream 1 년 전
SONN under $2
👍️0
crowin crowin 1 년 전
Chardan Capital Maintains Buy on Sonnet BioTherapeutics, Lowers Price Target to $30
👍️0
maq1214 maq1214 1 년 전
This should get exciting soon, crazy volume yesterday !
👍️0
BooDog BooDog 1 년 전
IS it just greed or might this make good for another round trip? We'll see next week.
👍️0
BooDog BooDog 1 년 전
Good move IMO. Surprising actually.

On December 27, 2023, the Compensation Committee (the “Committee”) of the Board of Directors of Sonnet BioTherapeutics Holdings, Inc. (the “Company”) cancelled accrued but unpaid bonuses (the “Cancelled Bonuses”) that had been awarded for fiscal years 2022 and 2023 by the Committee to certain executive officers and employees of the Company. The Cancelled Bonuses total $1,930,773.10 and include (i) $631,768.12 awarded to Pankaj Mohan, Ph.D., the Company’s President and Chief Executive Officer, (ii) $312,741.79 awarded to John Cini, Ph.D, the Company’s Chief Scientific Officer and (iii) $364,504.40 awarded to Jay Cross, the Company’s Chief Financial Officer.

https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/92897290/form-8-k-current-report
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
BooDog BooDog 1 년 전
Discount. Maybe I should have added "again". 1.60 offering and this is pushing towards the $. Very small float. Just playing the bounce. IF there is one lol.

https://www.accesswire.com/viewarticle.aspx?id=796208
👍️0
valleybenedetto valleybenedetto 1 년 전
Absolute piece of shit co, shit stock, dilution is endless. CEO should be fired. Sell now
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0
valleybenedetto valleybenedetto 1 년 전
If they would stop shitting on shareholders, cut costs and actually get something accomplished that would be a start.
👍️0
Monksdream Monksdream 1 년 전
If the stock continues to make new lows on its way to a delisting to Cromwell Coulson’s stock market or a dissolution I will continue to record it
👍️0
valleybenedetto valleybenedetto 1 년 전
You worry about you ok?
👍️0
Monksdream Monksdream 1 년 전
You aren’t getting any money back
Time to move on
👍️0
valleybenedetto valleybenedetto 1 년 전
Not an Urban Myth ..I've already checked. They have current D and O insurance.
👍️0
Monksdream Monksdream 1 년 전
Oh goddamn tell me another urban myth
👍️0
valleybenedetto valleybenedetto 1 년 전
They have D and O insurance. That's where you collect from. That's directors and officers insurance if you didn't know
👍️0
Monksdream Monksdream 1 년 전
You wouldn’t get anything from a class action lawsuit
Anyone connected to professional asset management abandoned this company long ago
👍️0
valleybenedetto valleybenedetto 1 년 전
CEO is awful. Nothing but offerings and RS. No meaningful news in months. Class action suit might be in order here.
👍️0
Monksdream Monksdream 1 년 전
SONN new 52 week low
👍️0

최근 히스토리

NASDAQ
SONN
Sonnet BioTherapeutics
BTHB
ROMKRW
ROMToken
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지